Mastering Emerging Therapies in Advanced Urothelial Cancer: Practical Strategies for Combination Therapies, Adverse Event Management, and Team-Based Care

Emerging clinical trial data are rapidly reshaping the treatment landscape for metastatic urothelial cancer (mUC) and driving updates to clinical practice guidelines.Tune is a nationally renowned genitourinary oncologist evaluates data from the latest clinical trials on the efficacy of combination immunotherapy regimens and review updates to clinical guidelines in mUC. This session also delves into strategies for mitigating immune-related adverse events as well as the best practices for providing adequate supportive care and maintaining quality of life of patients.Additionally, faculty will explore the roles of the broader healthcare team and the role of multidisciplinary collaboration and shared decision-making in improving patient care. Participants will be provided with downloadable resources, including a perioperative checklist with best practices for shared decision-making and an adverse event management point-of-care resource designed to support evidence-based toxicity management in everyday clinical practice.Don’t miss this unique opportunity to sharpen your clinical skills and gain practical strategies for integrating cutting-edge data into clinical practice.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Target Specialties

No specific specialties targeted.

Pricing

Free

Reported to ACCME by the provider

Enduring / On-demand
Credit · Up to 1 credit
Commercial Support

Available from

Nov 19, 2026
Last day to claim credit

Nov 19, 2027 1 year left

Mastering Emerging Therapies in Advanced Urothelial Cancer: Practical Strategies for Combination Therapies, Adverse Event Management, and Team-Based Care

Related courses

More from PRIME Education, Inc. (PRIME®)